|
1
|
WHO/NHLBI Workshop report: Global strategy
for asthma management and prevention. National Institutes of
Health/National Heart. Lung and Blood Institue. (NIH Publication
02-3659). Bethesda: 2005
|
|
2
|
Leff AR: Role of leukotrienes in bronchial
hyperresponsiveness and cellular responses in airways. Am J Respir
Crit Care Med. 161:S125–S132. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Broide DH, Lotz M, Cuomo AJ, Coburn DA,
Federman EC and Wasserman SI: Cytokines in symptomatic asthma
airways. J Allergy Clin Immunol. 89:958–967. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Krause K, Metz M, Makris M, Zuberbier T
and Maurer M: The role of interleukin-1 in allergy-related
disorders. Curr Opin Allergy Clin Immunol. 12:477–484. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Luster AD and Tager AM: T-cell trafficking
in asthma: lipid mediators grease the way. Nat Rev Immunol.
4:711–724. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
O’Byrne PM: Leukotriene
bronchoconstriction induced by allergen and exercise. Am J Respir
Crit Care Med. 161:S68–S72. 2000. View Article : Google Scholar
|
|
7
|
Serhan CN: Lipoxins and aspirin-triggered
15-epi-lipoxin biosynthesis: an update and role in
anti-inflammation and pro-resolution. Prostaglandins Other Lipid
Mediat. 68:433–455. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee TH, Lympany P, Crea AK and Spur BW:
Inhibition of leukotriene B4-induced neutrophil migration by
lipoxin A4: structure-function relationships. Biochem Biophys Res
Commun. 180:1416–1421. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu SH, Liao PY, Yin PL, Zhang YM and Dong
L: Elevated expressions of 15-lipoxygenase and lipoxin A4 in
children with acute poststreptococcal glomerulonephritis. Am J
Pathol. 174:115–122. 2009. View Article : Google Scholar :
|
|
10
|
Levy BD, Lukacs NW, Berlin AA, Schmidt B,
Guilford WJ, Serhan CN and Parkinson JF: Lipoxin A4 stable analogs
reduce allergic airway responses via mechanisms distinct from
CysLT1 receptor antagonism. FASEB J. 21:3877–3884. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Levy BD, De Sanctis GT, Devchand PR, Kim
E, Ackerman K, Schmidt BA, Szczeklik W, Drazen JM and Serhan CN:
Multi-pronged inhibition of airway hyper-responsiveness and
inflammation by lipoxin A4. Nat Med. 8:1018–1023. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bonnans C, Vachier I, Chavis C, Godard P,
Bousquet J and Chanez P: Lipoxins are potential endogenous
antiinflammatory mediators in asthma. Am J Respir Crit Care Med.
165:1531–1535. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu SH, Liao PY, Dong L and Chen ZQ: Signal
pathway involved in inhibition by lipoxin A(4) of production of
interleukins induced in endothelial cells by lipopolysaccharide.
Inflamm Res. 57:430–437. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Faure E, Equils O, Sieling PA, Thomas L,
Zhang FX, Kirschning CJ, Polentarutti N, Muzio M and Arditi M:
Bacterial lipopolysaccharide activates NF-kappaB through toll-like
receptor 4 (TLR4) in cultured human dermal endothelial cells.
Differential expression of TLR-4 and TLR-2 in endothelial cells. J
Biol Chem. 275:11058–11063. 2000. View Article : Google Scholar
|
|
15
|
Hoth JJ, Wells JD, Brownlee NA, Hiltbold
EM, Meredith JW, McCall CE and Yoza BK: Toll-like receptor
4-dependent responses to lung injury in a murine model of pulmonary
contusion. Shock. 31:376–381. 2009. View Article : Google Scholar
|
|
16
|
Sabroe I, Parker LC, Wilson AG, Whyte MK
and Dower SK: Toll-like receptors: their role in allergy and
non-allergic inflammatory disease. Clin Exp Allergy. 32:984–989.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Redecke V, Häcker H, Datta SK, Fermin A,
Pitha PM, Broide DH and Raz E: Cutting edge: activation of
Toll-like receptor 2 induces a Th2 immune response and promotes
experimental asthma. J Immunol. 172:2739–2743. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Eisenbarth SC and Flavell RA: Innate
instruction of adaptive immunity revisited: the inflammasome. EMBO
Mol Med. 1:92–98. 2009. View Article : Google Scholar
|
|
19
|
Velasco G, Campo M, Manrique OJ, Bellou A,
He H, Arestides RS, Schaub B, Perkins DL and Finn PW: Toll-like
receptor 4 or 2 agonists decrease allergic inflammation. Am J
Respir Cell Mol Biol. 32:218–224. 2005. View Article : Google Scholar
|
|
20
|
Wu SH, Wu XH, Liao PY and Dong L: Signal
transduction involved in protective effects of 15(R/S)-methyl-
lipoxin A(4) on mesangioproliferative nephritis in rats.
Prostaglandins Leukot Essent Fatty Acids. 76:173–180. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang L, Zhang X, Wu P, Li H, Jin S, Zhou
X, Li Y, Ye D, Chen B and Wan J: BML-111, a lipoxin receptor
agonist, modulates the immune response and reduces the severity of
collagen-induced arthritis. Inflamm Res. 57:157–162. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hecht I, Rong J, Sampaio AL, Hermesh C,
Rutledge C, Shemesh R, Toporik A, Beiman M, Dassa L, et al: A novel
peptide agonist of formyl-peptide receptor-like 1 (ALX) displays
anti-inflammatory and cardioprotective effects. J Pharmacol Exp
Ther. 328:426–434. 2009. View Article : Google Scholar
|
|
23
|
Cho JY, Miller M, Baek KJ, Castaneda D,
Nayar J, Roman M, Raz E and Broide DH: Immunostimulatory DNA
sequences inhibit respiratory syncytial viral load, airway
inflammation, and mucus secretion. J Allergy Clin Immunol.
108:697–702. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Loiarro M, Capolunghi F, Fantò N, Gallo G,
Campo S, Arseni B, Carsetti R, Carminati P, De Santis R, et al:
Pivotal advance: inhibition of MyD88 dimerization and recruitment
of IRAK1 and IRAK4 by a novel peptidomimetic compound. J Leukoc
Biol. 82:801–810. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gewirtz AT, Collier-Hyams LS, Young AN,
Kucharzik T, Guilford WJ, Parkinson JF, Williams IR, Neish AS and
Madara JL: Lipoxin a4 analogs attenuate induction of intestinal
epithelial proinflammatory gene expression and reduce the severity
of dextran sodium sulfate-induced colitis. J Immunol.
168:5260–5267. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu SH, Liu B, Dong L and Wu HJ: NF-kappaB
is involved in inhibition of lipoxin A4 on dermal inflammation and
hyperplasia induced by mezerein. Exp Dermatol. 19:e286–e288. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kaisho T and Akira S: Toll-like receptor
function and signaling. J Allergy Clin Immunol. 117:979–987. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li X and Qin JJ: Modulation of
Toll-interleukin 1 receptor mediated signaling. J Mol Med (Berl).
83:258–266. 2005. View Article : Google Scholar
|
|
29
|
Lee CC, Lai YT, Chang HT, Liao JW, Shyu
WC, Li CY and Wang CN: Inhibition of high-mobility group box 1 in
lung reduced airway inflammation and remodeling in a mouse model of
chronic asthma. Biochem Pharmacol. 86:940–949. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ferreira DS, Annoni R, Silva LF, Buttignol
M, Santos AB, Medeiros MC, Andrade LN, Yick CY, Sterk PJ, et al:
Toll-like receptors 2, 3 and 4 and thymic stromal lymphopoietin
expression in fatal asthma. Clin Exp Allergy. 42:1459–1471. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Simpson JL, Grissell TV, Douwes J, Scott
RJ, Boyle MJ and Gibson PG: Innate immune activation in
neutrophilic asthma and bronchiectasis. Thorax. 62:211–218. 2007.
View Article : Google Scholar
|
|
32
|
Bauer C, Kielian T, Wyatt TA, Romberger
DJ, West WW, Gleason AM and Poole JA: Myeloid differentiation
factor 88-dependent signaling is critical for acute organic
dust-induced airway inflammation in mice. Am J Respir Cell Mol
Biol. 48:781–789. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Krause K, Metz M, Makris M, Zuberbier T
and Maurer M: The role of interleukin-1 in allergy-related
disorders. Curr Opin Allergy Clin Immunol. 12:477–484. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nakae S, Komiyama Y, Yokoyama H, Nambu A,
Umeda M, Iwase M, Homma I, Sudo K, Horai R, et al: IL-1 is required
for allergen-specific Th2 cell activation and the development of
airway hypersensitivity response. Int Immunol. 15:483–490. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sim TC, Hilsmeier KA, Reece LM, Grant JA
and Alam R: Interleukin-1 receptor antagonist protein inhibits the
synthesis of IgE and proinflammatory cytokines by
allergen-stimulated mononuclear cells. Am J Respir Cell Mol Biol.
11:473–479. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nagarkar DR, Poposki JA, Comeau MR,
Biyasheva A, Avila PC, Schleimer RP and Kato A: Airway epithelial
cells activate TH2 cytokine production in mast cells through IL-1
and thymic stromal lymphopoietin. Allergy Clin Immunol.
130:225–232. 2012. View Article : Google Scholar
|
|
37
|
Wei-xu H, Qin X, Zhu W, Yuan-yi C, Li-feng
Z, et al: Therapeutic potential of anti-IL-1β IgY in guinea pigs
with allergic asthma induced by ovalbumin. Mol Immunol. 58:139–149.
2014. View Article : Google Scholar
|
|
38
|
Campo GM, Avenoso A, D’Ascola A, Scuruchi
M, Prestipino V, Nastasi G, Calatroni A and Campo S: Adenosine A2A
receptor activation and hyaluronan fragment inhibition reduce
inflammation in mouse articular chondrocytes stimulated with
interleukin-1β. FEBS J. 279:2120–2133. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Christie PE, Spur BW and Lee TH: The
effects of lipoxin A4 on airway responses in asthmatic subjects. Am
Rev Respir Dis. 145:1281–1284. 1992. View Article : Google Scholar : PubMed/NCBI
|
